Trial Profile
Reactive Household-based Self-administered Treatment Against Residual Malaria Transmission: a Cluster Randomized Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Dihydroartemisinin/piperaquine (Primary)
- Indications Malaria
- Focus Therapeutic Use
- Acronyms RHOST
- 04 Sep 2020 Status changed from active, no longer recruiting to completed.
- 22 May 2019 Status changed from recruiting to active, no longer recruiting.
- 28 Jan 2019 Planned End Date changed from 1 Jun 2019 to 1 Sep 2019.